Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 mars 2025 05h38 HE | Source: Research and Markets

Anti-Obesity Drugs Market Industry Trends, Sales Forecast, Key Players and Global Forecasts to 2035: Semaglutide & Tirzepatide Lead the Global Anti-Obesity Drug Market Boom

Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Mechanism of Action, Type of...
04 mars 2025 09h27 HE | Source: Research and Markets

Obesity 7 Major Market Research 2025: There will be an Increase in Therapies with Longer Duration of Action - Disease Management, Epidemiology, Pipeline Analysis, Unmet Needs and Drug Forecast to 2031

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031" report has been added to ...
30 août 2024 04h55 HE | Source: Research and Markets

Global GLP-1 Analogues Market Report 2024-2032: Market Expansion Driven by Innovation and Efficacy in Diabetes and Obesity Treatment - Single Dose and Zepbound Drive Market Domination

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose,...
04 juin 2024 04h17 HE | Source: Research and Markets

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%

Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis" report has been...
07 mai 2024 10h41 HE | Source: Research and Markets

Anti-Obesity Drugs Global Strategic Business Report 2024: Market to Reach $4.8 Billion by 2030 - Saxenda Commands the AOM Market, Newer Drugs to Provide Impetus to Market Growth

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Anti-Obesity Drugs Market to...
11 avr. 2024 11h14 HE | Source: Research and Markets

Global Anti-obesity Medication Market Trends Analysis Report 2024-2030: Social Media Influences and Strategic Partnerships, Mergers, Acquisitions, and Collaborations Shaping the Landscape

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market Size, Share & Trends Analysis Report" report has been added to ResearchAndMarkets.com's offering.The global...
20 déc. 2023 10h38 HE | Source: Research and Markets

Anti-Obesity Drug Market to Witness Robust Growth Through 2028 Amid Rising Global Obesity Concerns

Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Anti-obesity Drug Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.The anti-obesity drug market is...